The Food and Drug Administration seized more than a thousand documents from e-cigarette maker Juul Labs last week in a surprise inspection, according to The New York Times. The agency said the documents were related to Juul’s sales and marketing practices.
A study published earlier this year that concluded supervised drug injection sites may not be as effective in preventing drug overdose deaths as previously thought has been retracted.
This website uses cookies. We use cookies and similar technologies to give
you the best experience. By using this website, you accept our Privacy Policy and Terms of Use.